Abstract
Cellular uptake of platinum-based antitumor drugs is a critical step in the mechanism of the drug action and associated resistance, and deeper understanding of this step may inspire development of novel methods for new drugs with reduced resistance. Human copper transporter 1 (hCtr1), a copper influx protein, was recently found to facilitate the cellular entry of several platinum drugs. In the work reported here, we constructed a Met- and His-rich 20mer peptide (hCtr1-N20) corresponding to the N-terminal domain of hCtr1, which is the essential domain of hCtr1 for transporting platinum drugs. The interactions of the peptide with cisplatin and its analogues, including transplatin, carboplatin, oxaliplatin, and [Pt(l-Met)Cl2], were explored at the molecular level. Electrospray ionization (ESI) mass spectrometry (MS) data revealed that all of the platinum(II) complexes used in present study can bind to hCtr1-N20 in 1:1 and 2:1 stoichiometry. Four Met residues should be involved in binding to cis-platinum complexes on the basis of the tandem MS spectrometry and previously reported data. Time-dependent 2D [1H,15N] heteronuclear single quantum coherence NMR spectra indicate the reaction of cisplatin with hCtr1-N20 is a stepwise process. The intermediate, however, is transient, which is consistent with the ESI-MS results. Time-dependent ESI-MS data revealed that the geometry and the properties of both the leaving and the nonleaving groups of platinum(II) complexes play essential roles in controlling the reactivity and formation of the final products with hCtr1-N20.
Similar content being viewed by others
References
Kelland L (2007) Nat Rev Cancer 7:573–584
Boulikas T, Vougiouka M (2003) Oncol Rep 10:1663–1682
Wang D, Lippard SJ (2005) Nat Rev Drug Discov 4:307–320
Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo Y-M, Rochdi M, Howell SB (2002) Cancer Res 62:6559–6565
Jung YW, Lippard SJ (2007) Chem Rev 107:1387–1407
Zhang SZ, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, Lippard SJ, Giacomini KM (2006) Cancer Res 66:8847–8857
Safaei R (2006) Cancer Lett 234:34–39
Samimi G, Safaei R, Katano K, Holzer AK, Rochdi M, Tomioka M, Goodman M, Howell SB (2004) Clin Cancer Res 10:4661–4669
Komatsu M, Sumizawa T, Mutoh M, Chen ZS, Terada K, Furukawa T, Yang XL, Gao H, Miura N, Sugiyama T, Akiyama S (2000) Cancer Res 60:1312–1316
Ishida S, Lee J, Thiele DJ, Herskowitz I (2002) Proc Natl Acad Sci USA 99:14298–14302
Lin XJ, Okuda T, Holzer A, Howell SB (2002) Mol Pharmacol 62:1154–1159
Klomp AEM, Tops BBJ, van den Berg IET, Berger R, Klomp LWJ (2002) Biochem J 364:497–505
Puig S, Lee J, Lau M, Thiele DJ (2002) J Biol Chem 277:26021–26030
Song IS, Savaraj N, Siddik ZH (2005) Mol Cancer Ther 4:864
Aller SG, Unger VM (2006) Proc Natl Acad Sci USA 103:3627–3632
Sinani D, Adle DJ, Kim H, Lee J (2007) J Biol Chem 282:26775–26785
Freeman HC, Golomb ML (1970) J Chem Soc D Chem Commun 1523–1524
Kerrison SJS, Sadler PJ (1977) J Chem Soc Chem Commun 861–863
Case DA, Darden TA, Cheatham TE I, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Pearlman DA, Crowley MRCW, Zhang W, Wang B, Hayik S, Roitberg A, Seabra G, Wong KF, Paesani F, Wu X, Brozell S, Tsui V, Gohlke H, Yang L, Tan C, Mongan J, Hormak V, Cui G, Beroza P, Mathews DH, Schafmeister C, Ross WS, Kollman PA (2006) AMBER 9. University of California, San Francisco
Junmei Wang PC, Kollman PA (2000) J Comput Chem 21:1049–1074
Still WC, Tempczyk A, Hawley RC, Hendrickson T (1990) J Am Chem Soc 112:6127–6129
Simmerling C, Strockbine B, Roitberg AE (2002) J Am Chem Soc 124:11258–11259
Ivanov AI, Christodoulou J, Parkinson JA, Barnham KJ, Tucker A, Woodrow J, Sadler PJ (1998) J Biol Chem 273:14721–14730
Cox MC, Barnham KJ, Frenkiel TA, Hoeschele JD, Mason AB, He QY, Woodworth RC, Sadler PJ (1999) J Biol Inorg Chem 4:621–631
Peleg-Shulman T, Gibson D (2001) J Am Chem Soc 123:3171–3172
Peleg-Shulman T, Najajreh Y, Gibson D (2002) J Inorg Biochem 91:306–311
Najajreh Y, Shulman TP, Moshel O, Farrell N, Gibson D (2003) J Biol Inorg Chem 8:167–175
Casini A, Gabbiani C, Mastrobuoni G, Messori L, Moneti G, Pieraccini G (2006) ChemMedChem 1:413–417
Calderone V, Casini A, Mangani S, Messori L, Orioli PL (2006) Angew Chem Int Ed 45:1267–1269
Weidt SK, Mackay CL, Langridge-Smith PRR, Sadler PJ (2007) Chem Commun 2542
Arnesano F, Scintilla S, Natile G (2007) Angew Chem Int Ed 46:9062–9064
Kasherman Y, Sturup S, Gibson D (2009) J Biol Inorg Chem 14:387–399
Reedijk J (1999) Chem Rev 99:2499–2510
Norman RE, Ranford JD, Sadler PJ (1992) Inorg Chem 31:877–888
Murdoch PD, Ranford JD, Sadler PJ, Berners-Price SJ (1993) Inorg Chem 32:2249–2255
Barnham KJ, Frey U, Murdoch PD, Ranford JD, Sadler PJ, Newell DR (1994) J Am Chem Soc 116:11175–11176
Knipp M, Karotki AV, Chesnov S, Natile G, Sadler PJ, Brabec V, Vasak M (2007) J Med Chem 50:4075–4086
Tang XJ, Thibault P, Boyd RK (1993) Anal Chem 65:2824–2834
Sze C, Khairallah G, Xiao Z, Donnelly P, O’Hair R, Wedd A (2009) J Biol Inorg Chem 14:163–165
Jiang JF, Nadas IA, Kim MA, Franz KJ (2005) Inorg Chem 44:9787–9794
Guo ZJ, Chen Y, Zang E, Sadler PJ (1997) J Chem Soc Dalton Trans 410:7–4111
Fan DM, Yang XL, Wang XY, Zhang SC, Mao JF, Ding J, Lin LP, Guo ZJ (2007) J Biol Inorg Chem 12:655–665
Davies MS, Cox JW, Berners-Price SJ, Barklage W, Qu Y, Farrell N (2000) Inorg Chem 39:1710–1715
Berners-Price SJ, Ronconi L, Sadler PJ (2006) Prog Nucl Magn Reson Spectrosc 49:65–98
Barnham KJ, Djuran MI, PdS Murdoch, Ranford JD, Sadler PJ (1996) Inorg Chem 35:1065–1072
Wei HY, Wang XY, Liu Q, Mei YH, Lu Y, Guo ZJ (2005) Inorg Chem 44:6077–6081
Lau JKC, Deubel DV (2005) Chem A Eur J 11:2849–2855
Cleare MJ, Hydes PC, Malerbi BW, Watkins DM (1978) Biochimie 60:835–850
Knox RJ, Friedlos F, Lydall DA, Roberts JJ (1986) Cancer Res 46:1972–1979
Davies MS, Berners-Price SJ, Hambley TW (2000) Inorg Chem 39:5603–5613
Acknowledgments
Financial support from the National Natural Science Foundation of China (nos. 20631020, 90713001, and 20721002) and the Natural Science Foundation of Jiangsu Province (BK2008015) is gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Wu, Z., Liu, Q., Liang, X. et al. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1. J Biol Inorg Chem 14, 1313–1323 (2009). https://doi.org/10.1007/s00775-009-0576-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-009-0576-7